SHR-2106
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 15, 2023
Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=58 | Enrolling by invitation | Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Not yet recruiting ➔ Enrolling by invitation
Enrollment open • Transplantation
July 17, 2023
Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=58 | Not yet recruiting | Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
New P1 trial • Transplantation
1 to 2
Of
2
Go to page
1